AT278397T
Dosage form comprising taxol in crystalline form
Abstract
The invention relates to a method for inhibiting stenosis or restenosis following a vascular trauma in a mammal host, including administering to the host therapeutically effective dose of cytostatic agent and / or cytoskeletal inhibitor so that biologically limit glass traumatized. Also it provides a method for inhibiting or reducing vascular reform following vascular trauma by administering an effective amount of cicloesquelético inhibitor. Further it provides a pharmaceutical composition and the assembly including a therapeutic agent of the invention.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
169 members in 11 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 82968597 | United States of America | A | |
| 82999197 | United States of America | A | |
| 9806322 | United States of America | W |
Members169
| Document | Office | Kind | |
|---|---|---|---|
| CA2145093A1 | Canada | A1 | |
| WO9407529A1 | World Intellectual Property Organization (WIPO) | A1 | |
| CA2154698A1 | Canada | A1 | |
| WO9416706A1 | World Intellectual Property Organization (WIPO) | A1 | |
| CA2162586A1 | Canada | A1 | |
| CA2162587A1 | Canada | A1 | |
| CA2455985A1 | Canada | A1 | |
| WO9426291A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO9426303A1 | World Intellectual Property Organization (WIPO) | A1 | |
| EP0681475A1 | European Patent Office (EPO) | A1 | |
| US5472985A | United States of America | A | |
| EP0752885A4 | European Patent Office (EPO) | A4 | |
| EP0702557A1 | European Patent Office (EPO) | A1 | |
| EP0710116A1 | European Patent Office (EPO) | A1 | |
| JPH08506112A | Japan | A | |
| US5545569A | United States of America | A | |
| CA2212537A1 | Canada | A1 | |
| CA2559392A1 | Canada | A1 | |
| WO9625176A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4985196A | Australia | A | |
| JPH08510209A | Japan | A | |
| JPH08510451A | Japan | A | |
| CA2223595A1 | Canada | A1 | |
| WO9640098A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU6277396A | Australia | A | |
| EP0752885A1 | European Patent Office (EPO) | A1 | |
| US5595722A | United States of America | A | |
| US5599844A | United States of America | A | |
| WO9640098A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP0809515A1 | European Patent Office (EPO) | A1 | |
| US5733925A | United States of America | A | |
| EP0833624A2 | European Patent Office (EPO) | A2 | |
| EP0702557A4 | European Patent Office (EPO) | A4 | |
| EP0710116A4 | European Patent Office (EPO) | A4 | |
| US5770609A | United States of America | A | |
| US5773479A | United States of America | A | |
| US5811447A | United States of America | A | |
| CA2285389A1 | Canada | A1 | |
| WO9843618A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO9843618A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US5847007A | United States of America | A | |
| JPH11500635A | Japan | A | |
| WO9843618A9 | World Intellectual Property Organization (WIPO) | A9 | |
| US5945456A | United States of America | A | |
| JPH11510479A | Japan | A | |
| US5981568A | United States of America | A | |
| EP0681475A4 | European Patent Office (EPO) | A4 | |
| EP0975340A2 | European Patent Office (EPO) | A2 | |
| BR9808109A | Brazil | A | |
| US6074659A | United States of America | A | |
| US6166090A | United States of America | A | |
| US6171609B1 | United States of America | B1 | |
| US6197789B1 | United States of America | B1 | |
| US6251920B1 | United States of America | B1 | |
| US6262079B1 | United States of America | B1 | |
| US6268390B1 | United States of America | B1 | |
| US6306421B1 | United States of America | B1 | |
| JP2001521503A | Japan | A | |
| US2002013275A1 | United States of America | A1 | |
| US2002025979A1 | United States of America | A1 | |
| US6358989B1 | United States of America | B1 | |
| US2002040064A1 | United States of America | A1 | |
| US6395494B1 | United States of America | B1 | |
| US2002068731A1 | United States of America | A1 | |
| US2002086896A1 | United States of America | A1 | |
| US2002182659A1 | United States of America | A1 | |
| US6491938B2 | United States of America | B2 | |
| US6515009B1 | United States of America | B1 | |
| US2003039675A1 | United States of America | A1 | |
| US2003083733A1 | United States of America | A1 | |
| US6569441B2 | United States of America | B2 | |
| EP0752885B1 | European Patent Office (EPO) | B1 | |
| AT244576T | Austria | T | |
| ATE244576T1 | Austria | T1 | |
| US6599928B2 | United States of America | B2 | |
| DE69233126D1 | Germany | D1 | |
| EP1350523A2 | European Patent Office (EPO) | A2 | |
| US2003203958A1 | United States of America | A1 | |
| DK0752885T3 | Denmark | T3 | |
| EP1350523A3 | European Patent Office (EPO) | A3 | |
| US6663881B2 | United States of America | B2 | |
| US6720350B2 | United States of America | B2 | |
| EP1407786A1 | European Patent Office (EPO) | A1 | |
| DE69233126T2 | Germany | T2 | |
| EP0809515B1 | European Patent Office (EPO) | B1 | |
| AT265233T | Austria | T | |
| ATE265233T1 | Austria | T1 | |
| DE69632310D1 | Germany | D1 | |
| EP1447098A2 | European Patent Office (EPO) | A2 | |
| DE69632310T2 | Germany | T2 | |
| EP0975340B1 | European Patent Office (EPO) | B1 | |
| AT278397TThis record | Austria | T | |
| ATE278397T1 | Austria | T1 | |
| ES2217306T3 | Spain | T3 | |
| US2004219223A1 | United States of America | A1 | |
| DE69826847D1 | Germany | D1 | |
| EP1510220A1 | European Patent Office (EPO) | A1 | |
| EP1512398A1 | European Patent Office (EPO) | A1 | |
| ES2226120T3 | Spain | T3 | |
| EP1447098A3 | European Patent Office (EPO) | A3 |
Showing 100 of 169
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 98914366
Titles2
- German
- VERWENDUNG VON CYTOSKELETTINHIBITOREN ZUR VORBEUGUNG DER RESTENOSE
- English
- USE OF CYTOSCELET INHIBITORS FOR PREVENTING RESTENOSIS
Classification
- CPC, 43
- A61K31/403
- A61K9/0024
- A61K9/0051
- A61K31/00
- A61K31/04
- A61K31/131
- A61K31/135
- A61K31/138
- A61K31/165
- A61K31/17
- A61K31/337
- A61K31/352
- A61K31/365
- A61K31/40
- A61K31/4025
- A61K31/4035
- A61K31/407
- A61K31/519
- A61K31/551
- A61K31/704
- A61K47/34
- A61K47/51
- A61K47/6803
- A61K47/6809
- A61K47/6817
- A61K47/6831
- A61K47/6843
- A61K47/6923
- A61K47/6927
- A61L31/08
- A61L31/148
- A61L31/16
- A61L2300/416
- A61L2300/432
- A61L2300/602
- A61L2300/606
- A61L2300/622
- A61L2300/63
- A61P7/00
- A61P9/00
- A61P9/14
- A61P43/00
- G01N2800/323
- IPC, 25
- A61K31 00
- A61K31 04
- A61K31 131
- A61K31 135
- A61K31 138
- A61K31 165
- A61K31 17
- A61K31 337
- A61K31 352
- A61K31 365
- A61K31 40
- A61K31 4025
- A61K31 4035
- A61K31 407
- A61K31 519
- A61K31 551
- A61K31 704
- A61K47 48
- A61K9 00
- A61L31 08
- A61L31 14
- A61L31 16
- A61P43 00
- A61P7 00
- A61P9 00